List of bibliographic references
Number of relevant bibliographic references: 12.
| Ident. | Authors (with country if any) | Title |
|---|
| 000003 (2005) |
Josef S. Smolen [Autriche] ; Kurt Redlich [Autriche] ; Jochen Zwerina [Autriche] ; Daniel Aletaha [Autriche] ; Günter Steiner [Autriche] ; Georg Schett [Autriche] | Pro-inflammatory cytokines in rheumatoid arthritis : Pathogenetic and therapeutic aspects |
| 000004 (2006) |
R. N. Maini [Royaume-Uni] ; P. C. Taylor [Royaume-Uni] ; J. Szechinski [Pologne] ; K. Pavelka [République tchèque] ; J. Bröll [Autriche] ; G. Balint [Hongrie] ; P. Emery [Royaume-Uni] ; F. Raemen [Belgique] ; J. Petersen [Danemark] ; J. Smolen [Autriche] ; D. Thomson [Royaume-Uni] ; T. Kishimoto [Japon] | Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in european patients with rheumatoid arthritis who had an incomplete response to methotrexate |
| 000012 (2007) |
Josef S. Smolen [Autriche] ; Daniel Aletaha [Autriche] ; Marcus Koeller [Autriche] ; Michael H. Weisman [États-Unis] ; Paul Emery [Royaume-Uni] | New therapies for treatment of rheumatoid arthritis |
| 000015 (2008) |
Tim Bongartz [États-Unis] ; Josef S. Smolen [Autriche] ; Andre Beaulieu [Canada] ; Andrea Rubbert-Roth [Allemagne] ; Cesar Ramos-Remus [Mexique] ; Josef Rovensky [Slovaquie] ; Emma Alecock [Royaume-Uni] ; Thasia Woodworth [Royaume-Uni] ; Rieke Alten [Allemagne] | Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study) : a double-blind, placebo-controlled, randomised trial. Commentary |
| 000047 (2010) |
Patrick Garnero [France] ; Elizabeth Thompson [Royaume-Uni] ; Thasia Woodworth [Royaume-Uni] ; Josef S. Smolen [Autriche] | Rapid and Sustained Improvement in Bone and Cartilage Turnover Markers With the Anti-Interleukin-6 Receptor Inhibitor Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Substudy of the Multicenter Double-Blind, Placebo-Controlled Trial of Tocilizumab in Inadequate Responders to Methotrexate Alone |
| 000060 (2010) |
J. L. Nam [Royaume-Uni] ; K. L. Winthrop [États-Unis] ; R. F. Van Vollenhoven [Suède] ; K. Pavelka [République tchèque] ; G. Valesini [Italie] ; E. M. A. Hensor [Royaume-Uni] ; G. Worthy [Royaume-Uni] ; R. Landewe [Pays-Bas] ; J. S. Smolen [Autriche] ; P. Emery [Royaume-Uni] ; M. H. Buch [Royaume-Uni] | Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA |
| 000103 (2011) |
Josef S. Smolen [Autriche] ; Daniel Aletaha [Autriche] | Interleukin-6 Receptor Inhibition With Tocilizumab and Attainment of Disease Remission in Rheumatoid Arthritis: The Role of Acute-Phase Reactants |
| 000145 (2011) |
E. Terpos [Grèce] ; K. Fragiadaki [Grèce] ; M. Konsta [Grèce] ; C. Bratengeier [Autriche] ; A. Papatheodorou [Grèce] ; P. P. Sfikakis [Grèce] | Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis |
| 000174 (2012) |
Josef S. Smolen [Autriche] ; José C. Martinez Avila [Autriche] ; Daniel Aletaha [Autriche] | Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction |
| 000175 (2012) |
Monika Schoels [Autriche, États-Unis] ; Daniel Aletaha [Autriche] ; Josef S. Smolen [Autriche] ; John B. Wong [États-Unis] | Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis |
| 000189 (2012) |
Vivian P. Bykerk [États-Unis, Canada] ; Andrew J. K. Östör [Royaume-Uni] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Winfried Graninger [Autriche] ; William Bensen [Canada] ; Michael T. Nurmohamed [Pays-Bas] ; Andreas Krause [Allemagne] ; Corrado Bernasconi [Suisse] ; Andrea Stancati [Suisse] ; Jean Sibilia [France] | Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice |
| 000218 (2013) |
Mark C. Genovese [États-Unis, Allemagne, Autriche, Canada, Espagne, Royaume-Uni, Suède] ; Andrea Rubbert-Roth ; Josef S. Smolen ; Joel Kremer ; Majed Khraishi ; Juan Gomez-Reino ; Anthony Sebba ; Robert Pilson ; Sarah Williams ; Ronald Van Vollenhoven | Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PascalFrancis/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/AffPays.i -k "Autriche"
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/AffPays.i \
-Sk "Autriche" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= PascalFrancis
|étape= Curation
|type= indexItem
|index= AffPays.i
|clé= Autriche
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
